This finding is supported in mouse lymphedema models and human samples from breast cancer-related lymphedema, in which lymphatic injury results in a Th2-biased response with the infiltration of large numbers of CD4+ IL-4+ IL-13+ Th2 cells (Figure 1) [26,38]. The gene discussed is CD4; the disease is breast cancer.